GlassScriptPhysician profile
Brice C Hsu
NPI 1902422793
$1,494.93
in general payments reported to CMS, 2019-2025
14 companies · $702 in 2025
The $702 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $281 · 2022: $263 · 2023: $148 · 2024: $102 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908 · Travel and Lodging: $42.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.39 |
| Travel and Lodging | $42.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $425.22 | 2022-2025 | Dailies Total1, Precision7, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $232.28 | 2023-2025 | Acuvue |
| Coopervision INC. | $155.51 | 2022-2025 | Onefit Contact Lens, Misight Contact Lens |
| Aerie Pharmaceuticals, INC. | $124.99 | 2021 | |
| Kala Pharmaceuticals, INC. | $95.92 | 2021 | |
| Glaukos Corporation | $93.12 | 2022 | |
| Sun Pharmaceutical Industries INC. | $92.97 | 2025 | |
| Bausch & Lomb Americas INC. | $69.84 | 2025 | Infuse, Scoutpro Osmolarity System |
| Novartis Pharmaceuticals Corporation | $60.04 | 2021 | |
| Rxsight INC | $34.36 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Mallinckrodt Hospital Products INC. | $29.33 | 2025 | Acthar |
| Biotissue Holdings INC. | $28.52 | 2025 | |
| Dompe US, INC. | $27.00 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $25.83 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brice Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.